Markets
International Flavors & Fragrances Inc (IFF) is set for another landmark as it hit the volume of 3.64 million
Witnessing the stock’s movement on the chart, on Thursday, International Flavors & Fragrances Inc (NYSE: IFF) set off with pace ...
Cerence Inc (CRNC) recently have taken one step ahead with the beta value of 2.58
Cerence Inc (NASDAQ: CRNC) started the day on Thursday, with a price decrease of -6.26% at $8.54, before settling in ...
LifeMD Inc (LFMD) recent quarterly performance of -28.15% is not showing the real picture
LifeMD Inc (NASDAQ: LFMD) open the trading on Thursday, with a bit cautious approach as it glided -8.88% to $4.62, ...
UroGen Pharma Ltd (URGN) is predicted to post EPS of -0.48 in the upcoming quarter : This Stock is Ticking Every Box for Top Investors
As on Thursday, UroGen Pharma Ltd (NASDAQ: URGN) started slowly as it slid -4.85% to $23.92, before settling in for ...
Beam Therapeutics Inc (BEAM) EPS is poised to hit -1.14 next quarter: How Investors Can Make It Count the Most?
Beam Therapeutics Inc (NASDAQ: BEAM) flaunted slowness of -0.96% at $21.66, as the Stock market unbolted on Thursday, before settling ...
Pay Attention to this Trade Activity as CMB.Tech NV (CMBT) last week performance was 7.68%
Witnessing the stock’s movement on the chart, on Thursday, CMB.Tech NV (NYSE: CMBT) set off with pace as it heaved ...
Shoe Carnival, Inc (SCVL) is set for another landmark as it hit the volume of 0.68 million
Shoe Carnival, Inc (NASDAQ: SCVL) started the day on Thursday, with a price increase of 3.42% at $17.52, before settling ...
Westlake Corporation (WLK) 20 Days SMA touch -8.21%: Odds are Looking very much in favour
Westlake Corporation (NYSE: WLK) open the trading on Thursday, with great promise as it jumped 3.34% to $64.91, before settling ...
Xilio Therapeutics Inc (XLO) recent quarterly performance of -1.06% is not showing the real picture
As on Thursday, Xilio Therapeutics Inc (NASDAQ: XLO) started slowly as it slid -9.28% to $0.7, before settling in for ...
Nektar Therapeutics (NKTR) recently have taken one step ahead with the beta value of -1.05
Nektar Therapeutics (NASDAQ: NKTR) flaunted slowness of -6.45% at $53.95, as the Stock market unbolted on Thursday, before settling in ...
